9 results on '"Wenwen Ning"'
Search Results
2. A retrospective cohort study on the effects of Down’s screening markers and maternal characteristics on pregnancy outcomes in preeclampsia
- Author
-
Bin Wu, Wenwen Ning, Yijie Chen, Caihe Wen, Huimin Zhang, and Yiming Chen
- Subjects
Fetal Growth Retardation ,Cesarean Section ,Physiology ,Pregnancy Outcome ,Hydronephrosis ,General Medicine ,Cicatrix ,Pregnancy Trimester, First ,Pre-Eclampsia ,Pregnancy ,Prenatal Diagnosis ,Internal Medicine ,Humans ,Pregnancy-Associated Plasma Protein-A ,Premature Birth ,Chorionic Gonadotropin, beta Subunit, Human ,Female ,Down Syndrome ,Biomarkers ,Retrospective Studies - Abstract
To investigate the effects of down's screening markers and maternal characteristics on preeclampsia (PE) pregnancy outcome during early and middle pregnancy.A retrospective study of a cohort of 246 PE and 18,709 No-PE pregnant women who participated in Down's screening during early and middle pregnancy was performed. Clinical data of pregnancy-related were collected. Multivariate binary logistic regression was used to analyze the adjusted odds ratio (aOR) and 95% confidence interval (CI) of Down's screening markers, maternal characteristics, pregnancy outcome, and other related variables, and to evaluate the influencing factors of each indicator on PE.Compared with the non-PE group, the concentration and median multiple (MoM) of pregnancy-associated plasma protein-A (PAPP-A) and free beta subunit of human chorionic gonadotropin (free β-hCG) in PE group were both lower (Decreased maternal serum PAPP-A level, increased free β-hCG, hyperlipemia, premature delivery, cesarean section, live birth, hydronephrosis, fetal growth retardation, low birth weight, and infection are risk factors for PE, while uterine scar and premature rupture of membrane are protective factors for PE.
- Published
- 2022
3. Construction and predictive value of risk models of maternal serum alpha-fetoprotein variants and fetal open neural tube defects
- Author
-
Yiming Chen, Xue Wang, Yijie Chen, WenWen Ning, Lei Chen, Yixuan Yin, Wen Zhang, Jiejing Lian, and Hao Wang
- Subjects
Fetus ,Pregnancy ,Case-Control Studies ,Prenatal Diagnosis ,Humans ,Chorionic Gonadotropin, beta Subunit, Human ,Female ,Neural Tube Defects ,alpha-Fetoproteins ,Biomarkers ,General Biochemistry, Genetics and Molecular Biology ,Retrospective Studies ,Original Research - Abstract
The correlation of maternal serum alpha-fetoprotein (AFP) variants (AFP-L2, AFP-L3), free beta-human chorionic gonadotropin (free β-hCG), and open neural tube defects (ONTDs) during the second trimester, and the screening efficiency of different risk models remain indistinct. We conducted a retrospective case-control study, and studied 57 pregnant women with ONTD fetuses and 569 pregnant women with normal fetuses. The receiver operating characteristic curve method indicated the best cutoff value and area under the curve (AUC). The predictive value of ONTD risk models by free β-hCG, AFP, AFP-L2, and AFP-L3 was investigated via integrated discrimination improvement (IDI), net reclassification improvement (NRI), and decision curve analysis (DCA). Compared to the control group, AFP, AFP-L2, and AFP-L3 levels were significantly higher, while free β-hCG level was significantly lower in the study group. The triple-index model of free β-hCG + AFP-L2 + AFP-L3 and the dual-index model of AFP-L2 + AFP-L3 showed the best predictive values, respectively (AUC = 0.905; AUC = 0.885). The order of the single-index model AUCs was AFP-L3 > AFP-L2 > AFP > free β-hCG. The negative predictive value, false positive rate, and negative likelihood ratio of AFP-L2, AFP-L3 alone, or combined with free β- hCG were better than those of AFP alone; however, the positive likelihood ratio was the opposite. The replacement of AFP by AFP-L2 or AFP-L3 combined with free β-hCG increased the IDI and NRI for predicting ONTD. The top five DCAs were AFP-L2 + free β-hCG, free β-hCG, AFP-L3, AFP + free β-hCG, and AFP. Indicators of maternal serum free β-hCG, AFP-L2, and AFP-L3 in the second trimester exhibited high sensitivity and specificity screening for ONTD fetuses. Risk models constructed using AFP-L2 + AFP-L3 and AFP-L2 + AFP-L3 + free β-hCG demonstrated better screening efficiency.
- Published
- 2022
4. A Risk Model for Predicting Fetuses with Trisomy 21 Using Alpha-Fetoprotein Variants L2 Combined with Maternal Serum Biomarkers in Early Pregnancy
- Author
-
Yijie Chen, Huimin Zhang, Yiming Chen, Wenwen Ning, and Bin Wu
- Subjects
medicine.medical_specialty ,medicine.drug_class ,Trisomy ,Gastroenterology ,Fetus ,Pregnancy ,Serum biomarkers ,Prenatal Diagnosis ,Internal medicine ,medicine ,Humans ,Pregnancy-Associated Plasma Protein-A ,Chorionic Gonadotropin, beta Subunit, Human ,Retrospective Studies ,business.industry ,Area under the curve ,Obstetrics and Gynecology ,medicine.disease ,Blood proteins ,Pregnancy Trimester, First ,Case-Control Studies ,Biomarker (medicine) ,Female ,alpha-Fetoproteins ,Down Syndrome ,Gonadotropin ,business ,Alpha-fetoprotein ,Biomarkers - Abstract
To establish a risk prediction model and the clinical value of trisomy 21 using alpha-fetoprotein variants L2 (AFP-L2) combined with maternal serum biomarkers and nuchal translucency (NT) thickness in early pregnancy. A retrospective case–control study was conducted. The subjects were divided into the case group (n = 40) or the control group (n = 40). An enzyme-linked immunosorbent assay was used to measure the maternal serum AFP-L2 level in both groups. The AFP-L2 single-index or multi-index combined risk model was used to predict the efficiency of trisomy 21. The best cut-off value and area under the curve (AUC) were determined to evaluate the predictive efficacy of different risk models constructed by AFP-L2. The maternal serum AFP-L2 level in the case group was 1.59 (0.61–3.61) Multiple of medium (MoM), which was higher than 1.00 (0.39–2.12) MoM in the control group (P P P
- Published
- 2021
5. Diagnostic value of maternal alpha-fetoprotein variants in second-trimester biochemical screening for trisomy 21 and 18
- Author
-
Yiming Chen, Yijie Chen, Wenwen Ning, Wen Zhang, Liyao Li, Xiaoying Wang, Yixuan Yin, and Huimin Zhang
- Subjects
Multidisciplinary ,Pregnancy ,Pregnancy Trimester, Second ,Prenatal Diagnosis ,Humans ,Chorionic Gonadotropin, beta Subunit, Human ,Female ,Trisomy ,alpha-Fetoproteins ,Down Syndrome ,Biomarkers ,Trisomy 18 Syndrome - Abstract
To evaluate the clinical predictive value of serum alpha-fetoprotein variants (AFP-L2, AFP-L3) in combination with maternal serum prenatal screening biomarkers in predicting fetal trisomy 21 and trisomy 18. We analyze the data of singleton pregnant women at 15–20+6 weeks of 731,922 gravidas from October 2007 to September 2019. The research objects were separated into the following groups: control (n = 569), trisomy 21 (n = 116), and trisomy 18 (n = 52). The cases were diagnosed by chromosomal karyotypic analysis of amniotic fluid cells. Level of AFP-L2 and AFP-L3 were detected in maternal serum among control women and patients. Receiver operator characteristic analysis, detection rate, false positive rate, false negative rate, positive predictive value, negative predictive value, positive likelihood ratio and negative likelihood ratio, comprehensive discriminant improvement, net weight classification improvement, decision curve analysis and Hosmer–lemeshow (H-L) test were used to investigate the predictive value of free β-hCG, AFP, AFP-L2 and AFP-L3 on the risk models of trisomy 21, 18. There was a statistically significant difference in maternal serum AFP-L2 and AFP-L3 multiple of the median (MoM) among the trisomy 21, trisomy 18, and control groups. The AUCs of AFP-L2 and AFP-L3 for the screening trisomy 21 and trisomy 18 fetus were 0.785, 0.758 and 0.775, 0.754. According to ROC, the optimal cut-off values of AFP-L2 and AFP-L3 for predicting trisomy 21 and trisomy 18 fetuses all were 1.09 MoM and 1.30 MoM, respectively. The risk-calculation model constructed by AFP-L2 + AFP-L3 MoM manifested better efficiency than the original single-value truncation method using AFP MoM alone. Compared with different modeling methods, the AUC of trisomy 21 fetuses predicted by AFP-L2 + AFP-L3 + free β-hCG achieved an optimal value (0.938), while the AUC of trisomy 18 fetus predicted by AFP-L2 + free β-hCG was the best (0.991). Compared with AFP, the IDI of AFP-L2 or AFP-L3 alone increased 9.56% and 12.34%; the NRI increased 26.50% and 26.70 in predicting trisomy 21. For trisomy 18, the IDI of AFP-L2 or AFP-L3 alone declined with 8.12% and 1.52%; the NRI declined with 13.84% and 8.54%. In the combined model, the model with best detection rate, false positive rate and positive likelihood ratio was AFP-L2 + AFP-L3 + free β-hCG, followed by AFP-L2 + free β-hCG and AFP-L3 + free β-hCG, and finally AFP + free β-hCG. Maternal serum AFP-L2 and AFP-L3 in the second trimester is a good marker for screening trisomy 21 and trisomy18 with high sensitivity and specificity. The combined screening results are better than the single marker, and the efficiency of AFP-L2 + AFP-L3 + free β-hCG is the best.
- Published
- 2022
6. External Quality Assessment of Maternal Serum Levels of Alpha-Fetoprotein, Free Beta-Human Chorionic Gonadotropin, and Unconjugated Estriol in Detecting Down Syndrome and Neural Tube Defects in the Second Trimester of 87 Maternal Serum Samples, Based on 105-139 Days
- Author
-
Yiming Chen, Yijie Chen, Yezhen Shi, Wenwen Ning, Xiaoying Wang, Liyao Li, and Huimin Zhang
- Subjects
Estriol ,Pregnancy ,Pregnancy Trimester, Second ,Prenatal Diagnosis ,Humans ,Reproducibility of Results ,Chorionic Gonadotropin, beta Subunit, Human ,Female ,General Medicine ,Neural Tube Defects ,alpha-Fetoproteins ,Down Syndrome ,Biomarkers - Abstract
BACKGROUND We aimed to insure the accuracy and reproducibility of alpha-fetoprotein (AFP), free beta-human chorionic gonadotropin (free ß-hCG), and unconjugated estriol (uE3) concentrations for the screening for trisomy 21 (T21) and neural tube defects (NTD) in the second trimester. We conducted an external quality assessment of 6 laboratories, using maternal serum specimens. MATERIAL AND METHODS Serum specimens collected from 87 women of singleton pregnancies (4 with T21, 5 with NTD, and 78 with normal fetuses) were divided into 6 equivalent-volume fractions and transported to 6 laboratories (A, B, C, D, E, and F). All laboratories used the time-resolved fluorescence analyzer and supporting reagents to measure concentrations of AFP, free ß-hCG, and uE3. The screening efficacies of T21 and NTD were compared with the certified or accredited status of the participants' quality systems. RESULTS Concentrations of AFP measured by laboratory F were low compared with those determined by the other 5 laboratories, and the differences were significant (P0.01). There was no statistically significant difference in the free ß-hCG and uE3 concentrations measured by the 6 laboratories (P0.05). The correlation coefficients for the 3 multiples of the median values were all0.900. The McNemar paired chi-squared test showed the differences in the positivity and detection rates were not statistically significant (P=1.000). CONCLUSIONS AFP, free ß-hCG, and uE3 values measured by the other 5 laboratories were comparable with those of laboratory A, with good linear correlation. When used in the maternal prenatal screening of T21 and NTD, the test results met the clinical requirements.
- Published
- 2022
7. Predicting Hypertensive Disease in the First Trimester of Pregnancy: Risk Models and Analysis of Serum D-dimer Levels Combined with Plasma Pregnancy-Associated Protein A, Free
- Author
-
Yiming, Chen, Wenwen, Ning, Xuelian, Chu, Yijie, Chen, Linyuan, Gu, Zhen, Xie, Liyao, Li, Caihe, Wen, and Xiaoying, Wang
- Subjects
Hypertension, Pregnancy-Induced ,Chorionic Gonadotropin ,Cohort Studies ,Fibrin Fibrinogen Degradation Products ,Pregnancy Trimester, First ,Pre-Eclampsia ,Pregnancy ,Prenatal Diagnosis ,Humans ,Pregnancy-Associated Plasma Protein-A ,Chorionic Gonadotropin, beta Subunit, Human ,Female ,Nuchal Translucency Measurement ,Staphylococcal Protein A ,Biomarkers ,Retrospective Studies - Abstract
We aimed to investigate the predictive ability of serum levels of D-dimer (DD) in the first trimester for the occurrence of hypertensive disorders of pregnancy (HDP). In this retrospective, case-cohort study, we measured the levels of DD, plasma pregnancy-associated protein A (PAPP-A), and free
- Published
- 2021
8. Second trimester maternal serum D-dimer combined with alpha-fetoprotein and free β-subunit of human chorionic gonadotropin predict hypertensive disorders of pregnancy: a systematic review and retrospective case–control study
- Author
-
Gu Linyuan, Caihe Wen, Xie Zhen, Yijie Chen, Wenwen Ning, Yiming Chen, Xue Wang, Li Liyao, and Chu Xuelian
- Subjects
Gestational hypertension ,medicine.medical_specialty ,lcsh:Medicine ,030204 cardiovascular system & hematology ,Likelihood ratios in diagnostic testing ,Gastroenterology ,Chorionic Gonadotropin ,General Biochemistry, Genetics and Molecular Biology ,Preeclampsia ,Human chorionic gonadotropin ,Fibrin Fibrinogen Degradation Products ,03 medical and health sciences ,0302 clinical medicine ,Pre-Eclampsia ,Pregnancy ,Internal medicine ,Prenatal Diagnosis ,D-dimer ,medicine ,Humans ,Retrospective Studies ,030219 obstetrics & reproductive medicine ,Receiver operating characteristic ,business.industry ,Research ,lcsh:R ,General Medicine ,Hypertension, Pregnancy-Induced ,medicine.disease ,Hypertensive disorders of pregnancy ,Case-Control Studies ,Pregnancy Trimester, Second ,Alpha-fetoprotein ,Female ,Free β subunit of human chorionic gonadotropin ,alpha-Fetoproteins ,business ,Biomarkers - Abstract
Background This study investigated whether maternal serum D-dimer (DD) alone or DD combined with alpha-fetoprotein (AFP) and free β-subunit of human chorionic gonadotropin (free β-hCG) in the second trimester could be used to predict hypertensive disorders of pregnancy (HDP). Materials and methods In this retrospective case–control study, the data of gravidas patients who delivered at hospital were divided into the following groups: control (n = 136), gestational hypertension (GH, n = 126), preeclampsia (PE, n = 53), and severe preeclampsia (SPE, n = 41). Receiver operator characteristic (ROC) curves were used to evaluate the diagnostic value of maternal serum DD, AFP, and free β-hCG levels for HDP. Results DD levels of the GH, PE, and SPE groups were significantly higher than that of the control group (P DD > DD + AFP > DD + free β-hCG > AFP + free β-hCG > AFP > free β-hCG. For predicting different types of HDP, DD alone had the best diagnostic value for SPE, followed by PE and GH. DD alone had a sensitivity of 100% with a 0% false negative rate and had the highest positive likelihood ratio (+ LR) for SPE. DD alone in combination with AFP alone, free β-hCG alone and AFP + free β-hCG could reduce false positive rate and improve + LR. Conclusion DD is possible the best individual predictive marker for predicting HDP. Levels of DD alone in the second trimester were positively correlated with the progression of elevated blood pressure in the third trimester, demonstrating the predicting the occurrence of HDP. The risk calculation model constructed with DD + free β-hCG + AFP had the greatest diagnostic value for SPE.
- Published
- 2021
9. A risk model that combines MAP, PlGF, and PAPP-A in the first trimester of pregnancy to predict hypertensive disorders of pregnancy
- Author
-
Yiming, Chen, Xue, Wang, Wensheng, Hu, Yijie, Chen, Wenwen, Ning, Sha, Lu, Pei, He, Liyao, Li, and Zhifen, Zhang
- Subjects
Hypertension, Pregnancy-Induced ,Pregnancy Trimester, First ,Pre-Eclampsia ,Predictive Value of Tests ,Pregnancy ,Case-Control Studies ,Humans ,Pregnancy-Associated Plasma Protein-A ,Arterial Pressure ,Female ,Staphylococcal Protein A ,Biomarkers ,Placenta Growth Factor ,Retrospective Studies - Abstract
Whether the first trimester maternal mean arterial pressure (MAP), placental growth factor (PlGF), and pregnancy-associated plasma protein A (PAPP-A) can predict hypertensive disorders of pregnancy (HDP) is unclear. We conducted a retrospective case-control study with the total population of 539 gravidas, of these 447 had normal pregnancy, 27 had gestational hypertension (GH), 36 had preeclampsia (PE), and 29 had preeclampsia with severe features (SPE). Prediction for HDP was determined by the area under curve (AUC). Compared to the healthy group, the multiple of the median (MoM) for MAP was increased in the study groups, while PlGF and PAPP-A were decreased. When the cutoff values for MAP, PlGF, and PAPP-A were 1.069, 0.769, and 0.673 MoM, respectively, the sensitivities for predicting HDP were 0.517, 0.446, and 0.500 and the specificities were 0.744, 0.826, and 0.769, respectively. To predict GH, the highest AUC was 0.755 (95% CI: 0.655-0.856, p 0.001) based on MAP, PlGF, and PAPP-A. The combined PlGF and PAPP-A had the highest AUC (0.683 [95% CI: 0.584-0.782, p 0.001] and 0.755 [95% CI: 0.682-0.829, p 0.001]) for prediction of PE and SPE. We found that MAP, serum levels of PlGF, and PAPP-A in the first trimester pregnancy are markers that predict HDP in the third trimester. The combination of markers is far superior to single markers alone. To improve the diagnostic value, specific cutoff values should be applied to GH, PE, SPE in each condition.
- Published
- 2020
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.